SOLD: Top 5 European CBD brand selling all CBD product categories into 8 EU countries.
Unique opportunity to purchase a European market-leading CBD brand and licensed facility in strategically-advantageous EU country
Listing ID:
7429879662
Licence(s) Held:
Hemp Cultivation, Processing, Sales & Distribution Licence
Listing Details:
A European market leader of high-quality, CBD-focused natural wellness products. In market since 2016 with well established brands.
One of the first companies to receive validation on their novel food application, a critical step in establishing a permanent distribution network throughout Europe
Experienced leadership team with deep operating experience and proven track record.
Company has built a broad product portfolio covering all CBD product categories, including oils, capsules and skincare.
Industrial scale CO2 extraction facility, testing lab, formulation lab and packaging lines with significant output capabilities.
Currently in growth mode, selling into 8 EU countries with rapidly expanding distribution and enhanced product offerings.
Projected revenues of $12.6 million Canadian in 2022, increasing to $24 million in 2023, with healthy profit margins.
Diverse, sustainable revenue streams spread across branded products including white label manufacturing, bulk oil and extraction services.
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.